Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at SAPA-GP 2023 Annual Conference

Page View:

Join Medicilon at SAPA-GP 2023 Annual Conference.webpReady to meet Medicilon at SAPA-GP 2023?

This time, you can not only visit our table, but also focus the speech “The biomarker oriented preclinical study in the era of cell& gene therapy” by our VP of Pharmacology, Pharmacodynamics department, Dr. Jing Deng


The theme of this year's conference is Embracing New Technologies in a Changing World, based on the huge changes experienced by different aspects of the pharmaceutical industry caused by the outbreak of the new crown in recent years. Our EVP of CMC, Dr. Zhenrong Guo and Medicilon team will be present throughout the conference!

Date: March 31st – April 1st, 2023
Location: Sheraton Valley Forge Hotel | King of Prussia, Pennsylvania

About SAPA-GP 2023

SAPA–GP is a key source for knowledge exchange on the latest developments in the pharmaceutical, biotechnology, and generic drug industries, the hidden gem for pharmaceutical professionals in the Greater Philadelphia area, the bridge for the pharmaceutical and healthcare industries between China and USA. 

5 Parallel Tracks discussed in this meeting:
❖Scientific: Pioneering a New Era of Drug Discovery & Development: Novel Targets, Innovative Platforms, and Recent Regulations
❖Clinical: New Trends in Clinical Development
❖Business: The Business Engine of New Drug Development: Fundraising, BD, and Commercialization
❖Market Research: Promoting Patient Access after Regulatory Approval

❖Career: Development, Diversity, Labor Law, and Roundtable Discussion

About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-stop new drug R&D services from ideal to pre-IND enabling stage for pharmaceutical enterprises and scientific research institutions around the world. We constantly develop new technology platform to grow with our global clients for their demanding for innovation and drug research. With our over 19 years experience in serving global pharmaceutical and novel drug discovery industries, we have built an integrated technical platform covering key technologies in small molecule and large molecuredrug discovery, in vivo and in vitro pharmacology research, and preclinical IND enabling research, to support drug research and development in today’s dynamic pharmaceutical  industry.

More Than 19 Years of Experience in New Drug R&D

Projects Successfully Approved with NMPA, FDA, EMA, and TGA

Active Clients Worldwide

New Drug Discovery Scientists and Service Personnel


Square Feet of Laboratory Floor Space

Preclinical Research Services

Pharmacology & Pharmacodynamics

Keeping pace with industrial development and market demand, Medicilon's Pharmacology and Pharmacodynamics Department boasts years of experience, and has established a complete animal model library based on verifications and practices for precise and efficient drug efficacy testing. The test subjects include non-human primates, dogs, rats/mice, rabbits, guinea pigs, and miniature pigs.

Drug Safety Evaluation

Medicilon has a quality management system for drug safety evaluation based on the internationally certified AAALAC quality standard and compliance with international and domestic GLP regulations.

Since 2008, we have continued to meet international standards and completed high-quality GLP safety evaluation services, establishing a long-term brand effect. Medicilon can perform systematic evaluation services covering multiple toxicity endpoints and has internationally recognized pathology studies to support our safety evaluation studies.


Our Preclinical Pharmacokinetics Department has a number of professionals with rich theoretical knowledge and experimental experience for experiment design, experiment implementation, bioanalysis and data analysis. Our Pharmacokinetics Lab has passed the GLP certification by NMPA. Following the guiding principles of ICH, NMPA and FDA. The lab offers in vivo and in vitro pharmacokinetic tests according to the needs of our clients and provide them with complete sets of pharmacokinetic evaluation and optimization services. Our acclaimed quality data collection and efficient experiment can meet our clients’ needs from early drug discovery to new drug filing.

IND Filings

Medicilon offers integrated preclinical R&D services, including chemistry, biology, pharmacodynamics evaluation, pharmacokinetics evaluation, and toxicology evaluation. Featuring responsive, timely project management and favorable prices, our integrated services promise quick and smooth project implementation.

Click here for more service platforms

Relevant newsRelevant news